Carbohydrate 3′-sialyllactose as a novel target for theranostics in pancreatic ductal adenocarcinoma
We previously demonstrated that the carbohydrate 3′-sialyllactose is overexpressed in cancer stem-like cells such as metastatic pancreatic and poorly differentiated gastric cancer cells, and undifferentiated human embryonic stem cells. In this study, we investigated the possibility of 3′-sialyllacto...
Saved in:
Main Authors: | Kiyoshi Higashi, Keiko Maeda, Kaori Miyata, Saori Yoshimura, Keita Yamada, Daijiro Konno, Taro Tachibana, Koichi Saito |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428320965279 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Coming of Age of Theranostic Cells
by: Seyed Moein Moghimi, et al.
Published: (2025-06-01) -
Understanding the heterogeneity of pancreatic ductal adenocarcinoma
by: Juan Iovanna, et al.
Published: (2025-10-01) -
Nanotechnology-based theranostics for bone tumors
by: Wenwen Zhan, et al.
Published: (2025-08-01) -
Microneedles at the Forefront of Next Generation Theranostics
by: Chan Wang, et al.
Published: (2025-06-01) -
MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)